ADC Therapeutics's chart data is dated 2026-10-08. Recorded technical signals: MACD bullish cross. There are 0 published signal records.
ADC Therapeutics last closed at $1.59 (+11.97%) on 2026-10-08. Signals today: MACD bullish cross. Listed on New York Stock Exchange. Trailing 12 months PER is -2.5×. Its overall grade ranks 44 of 738 stocks in Healthcare.
About this company
ADC Therapeutics last closed at $1.59 (+11.97%) on 2026-10-08. Signals today: MACD bullish cross. Listed on New York Stock Exchange.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 44/738
Valuation grade A+
Related stocks
- AstraZenecaCompetitor
ADC 항암제 개발·상업화 분야의 글로벌 경쟁사
- PfizerCompetitor
항체-약물접합체(ADC) 포함 항암제 시장의 대형 경쟁사
- SeagenCompetitor
ADC 분야 대표 선도기업으로 동종 기술·제품 경쟁
About ADC Therapeutics
- What technical signals does ADC Therapeutics (ADCT) have?
- ADC Therapeutics current technical signals: MACD bullish cross.
- Is ADC Therapeutics a cup-and-handle pattern?
- No. ADC Therapeutics has no valid Cup signal right now.
- What published figures are available for ADC Therapeutics?
- Market cap: $196.96M. Trailing 12 months PER: -2.5×. Latest quarter PBR: -1.08×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about ADC Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.